Genetics and COVID-19: How to Protect the Susceptible
- PMID: 32943209
- PMCID: PMC7456262
- DOI: 10.1016/j.tig.2020.08.019
Genetics and COVID-19: How to Protect the Susceptible
Abstract
Along with the potential for breakthroughs in care and prevention, the search for genetic mechanisms underlying the spread and severity of coronavirus disease 2019 (COVID-19) introduces the risk of discrimination against those found to have markers for susceptibility. We propose new legal protections to mitigate gaps in protections under existing laws.
Keywords: COVID-19; GINA; data privacy; genetic data; genetic discrimination.
Copyright © 2020 Elsevier Ltd. All rights reserved.
References
-
- Kofler N., Baylis F. Comment: ten reasons why immunity passports are a bad idea. Nature. 2020;581:379–381. - PubMed
-
- Drabiak K. Caveat emptor: how the intersection of big data and consumer genomics exponentially increases information privacy risks. Health Matrix. 2017;27:143–228.
-
- Koch V.G., Todd K. Research revolution or status quo? The new Common Rule and research arising from direct-to-consumer genetic testing. Hous. L. Rev. 2018;56:81–121.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
